Form 4 holding
CHIEF DEVELOPMENT OFFICER
KalVista Pharmaceuticals, Inc.
- Security class
- Restricted Stock Unit
- Shares / value
- 0
- Estimated value
- $399,108
- Report date
- 11 Jun 2026
- Price
- $9.82
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount